Cash Flow Statement Audited

Profit after tax

379.1

3,520.2

Depreciation/amortization and impairment losses (non-current assets)

1,215.3

923.6

Changes in inventories

–225.5

–170.5

Changes in trade receivables

–268.1

–152.6

Changes in trade payables

189.3

131.2

Changes in provisions

–71.0

53.2

Changes in other assets and liabilities

–187.3

–330.2

Gains/Losses on disposals of assets

–4.0

–3,481.3

Other non-cash income and expenses

–3.8

724.7

Net cash flows from operating activities

[33]

1,024.0

1,218.3

thereof: Discontinued Operations

–

36.9

Purchase of intangible assets

–140.9

–121.1

Purchase of property, plant and equipment

–394.7

–282.8

Acquisitions and investments in other financial assets

–78.2

–7,318.0

Disposal of non-current assets

35.7

4,995.8

Changes in securities

–7.5

34.7

Changes in other financial assets

503.9

–36.1

Net cash flows from investing activities

[34]

–81.7

–2,727.5

thereof: Discontinued Operations

–

4,797.9

Dividend payments

–212.5

–77.0

Capital increase including amounts due to stock option plans

0.2

2,038.4

Profit transfers to E. Merck KG and changes in reserves

–239.9

–535.8

Changes in liabilities to E. Merck KG

–291.0

396.4

Bonds issued

–

497.9

Changes in current and non-current financial liabilities

76.5

–827.1

Net cash flows from financing activities

[35]

–666.7

1,492.8

thereof: Discontinued Operations

–

–7.8

Changes in cash and cash equivalents

275.6

–16.4

Changes in cash and cash equivalents due to currency translation

–9.5

–17.1

Cash and cash equivalents as of January 1

426.6

460.1

Cash and cash equivalents as of December 31

[36]

692.7

426.6